Antibiotic resistance remains a growing concern worldwide, negatively impacting treatment outcomes for many infections. This firsthand account highlights how misdiagnosis and incorrect antibiotic usage—in this case, Cipro (ciprofloxacin)—can lead to serious complications. Cipro belongs to the fluoroquinolone class and is known to cause severe side effects, particularly affecting tendons and the immune system. People with connective tissue disorders such as Ehlers-Danlos syndrome are especially vulnerable, as their tendon and connective tissue integrity is already compromised. When facing persistent infections, it’s vital to ensure the prescribed antibiotic matches the infection type and resistance patterns. Incorrect prescriptions not only delay recovery but also increase risks of adverse effects and further resistance development. Extended courses of intravenous antibiotics, as experienced here, highlight the challenges of managing antibiotic-resistant infections. Patients should communicate any underlying conditions, especially connective tissue disorders, to healthcare providers before starting fluoroquinolones like Cipro. Awareness of the drug’s risks can prompt safer alternatives and prevent long-term damage. Furthermore, ongoing symptoms after antibiotic treatment underscore the need for careful monitoring and possibly alternative therapies. This story serves as a critical reminder of the importance of precise diagnostics and personalized treatment strategies to combat antibiotic resistance safely. It also stresses the need for patients to advocate for themselves and discuss the potential side effects and risks associated with their medications.